Literature DB >> 30842047

Combination or single-agent chemotherapy as adjuvant treatment for pancreatic cancer?

Thierry Conroy, Jean-Luc Van Laethem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30842047     DOI： 10.1016/S1470-2045(19)30107-X

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  2 in total

1.  UAE1 inhibition mediates the unfolded protein response, DNA damage and caspase-dependent cell death in pancreatic cancer.

Authors:  Yajing Liu; Sahezeel Awadia; Amy Delaney; Merna Sitto; Carl G Engelke; Heli Patel; Andrew Calcaterra; Sylvia Zelenka-Wang; Hojin Lee; Joseph Contessa; Nouri Neamati; Mats Ljungman; Theodore S Lawrence; Meredith A Morgan; Alnawaz Rehemtulla
Journal:  Transl Oncol       Date:  2020-07-17       Impact factor: 4.243

2.  Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.

Authors:  Shuai Ren; Xiao Chen; Wenjing Cui; Rong Chen; Kai Guo; Huifeng Zhang; Shuai Chen; Zhongqiu Wang
Journal:  Cancer Manag Res       Date:  2019-08-20       Impact factor: 3.989
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.